Bruker is one of the world's leading analytical instrumentation companies. Bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability.
Buckeye Composites is a new division of NanoTechLabs (NTL), the largest producer of multi-walled carbon nanotubes in the United States. With headquarters, research and manufacturing facilities in Yadkinville, North Carolina, NanoTechLabs has extensive commercial experience in materials development, focusing on the incorporation of nanomaterials into various materials systems and products.
Busek specializes in electric space propulsion and materials processing. Materials activities include deposition of coatings by ion beam deposition, sputtering, and by other methods. They have on-going development programs investigating DLC coating, the growth of carbon nanotubes, and other materials.
Cadence delivers application specific kits and new-generation platforms of integrated design technologies and methodologies that help users address all aspects of electronics design in the nanometer era.
California Lithium Battery applies a new Argonne patented process to embed nano-silicon into graphene that Argonne tests show help to stabilize the silicon to create a superior lithium battery anode material.
A leading provider of cutting-edge technologies enabling researchers in the life sciences to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper has compiled numerous best-in-class solutions and is aggressively innovating new technologies to bridge the gaps that exist in bringing in vitro assays to in vivo results and ultimately into cures for human disease.
Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize. The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer.